Maintenance notice: Some features that submit or update information are temporarily disabled while we migrate the website. You can continue browsing normally. Thank you for your understanding.
July 14, 2017
Two former sales representatives for an Arizona-based drug company pled guilty this week to participating in a multimillion-dollar kickback scheme designed to boost sales of a powerful prescription painkiller, federal officials announced.
The now-defunct program at Insys Therapeutics ostensibly involved paying doctors an “honorarium,” typically $1,000 to $3,000, in exchange for brief speeches at high-end restaurants to other health care professionals about the benefits of Subsys, a drug containing the opioid fentanyl.
“In truth, the events were usually just a gathering of friends and co-workers, most of whom did not have the ability to prescribe Subsys, and no educational component took place,” the U.S.
Improving orthopaedic care, education and research using Internet technologies